Bio-Rad Laboratories, Inc. Price Today
Bio-Rad Laboratories, Inc.
BIO
Healthcare
$11.46B
💰
Market Cap
0
💸
Price to Earnings
$-7.0
🎉
EPS
+83
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
7 |
Strong Buy |
3 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
BIO Price Forecast Target
400.0 👉 605.0 +51%
BIO EPS Forecast
-7.0 👉 15.9 +-327%
Financials
Profit Margin
-15 %
Revenue Growth
-1.4 %
Dividend
$ 0
Held Percent
14.5% - Insiders
80.7% - Institutions
4.8% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $958.9M
-
💰 Blackrock Inc. $639.4M
-
💰 Veritas Asset Management LLP $460.4M
-
💰 Brown Advisory Inc. $370.8M
-
💰 State Street Corporation $368.7M
Stock Ideas
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…📮FAQ
Some Frequently Asked Questions.
The Bio-Rad Laboratories, Inc. industry is Medical Devices
The Bio-Rad Laboratories, Inc. sector is Healthcare
The Bio-Rad Laboratories, Inc. forecasted predicted Price to Earnings PE ratio is 25.1
The Bio-Rad Laboratories, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of Bio-Rad Laboratories, Inc. is $11.46B
There are total of 20713904 float shares with 80.7% held by Institutions and 14.5% held by insiders
The MBio-Rad Laboratories, Inc. forecasted Earnings per Share EPS is $15.9
The Bio-Rad Laboratories, Inc. Earnings per Share EPS is -7.0
The Bio-Rad Laboratories, Inc. company has $1568430000 gross profits with -15 profit margins
The Bio-Rad Laboratories, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Bio-Rad Laboratories, Inc. Revenue is $2769041920 with -0.014 revenue growth
The price target for Bio-Rad Laboratories, Inc. stock is $605.0 for the high target and $510.0 for the low target
The consensus analyst recommendations for Bio-Rad Laboratories, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Bio-Rad Laboratories, Inc. is Buy, with the following breakdown:
- Buy: 7
- Strong Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of Bio-Rad Laboratories, Inc. is 0.9
The dividend of Bio-Rad Laboratories, Inc. is $0
The dividend yield of Bio-Rad Laboratories, Inc. is 0%
The biggest institutional and mutual fund holders of Bio-Rad Laboratories, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Veritas Asset Management LLP
- Brown Advisory Inc.
The Bio-Rad Laboratories, Inc. ESG Score is 83, with the following breakdown:
- E: 1.44
- S: 8.25
- G: 7.19